MaxCyte, Inc. Stock Issued During Period, Shares, Employee Stock Purchase Plans
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MaxCyte, Inc. stock issued during period, shares, employee stock purchase plans for the quarter ending 2024-12-31 was 70.84K shares.
- MaxCyte, Inc. stock issued during period, shares, employee stock purchase plans for the quarter ending 2024-09-30 was 0.00 shares.
- MaxCyte, Inc. stock issued during period, shares, employee stock purchase plans for fiscal 2025 was 130.65K shares, a 6.71% decline from fiscal 2024.
- MaxCyte, Inc. stock issued during period, shares, employee stock purchase plans for fiscal 2024 was 140.05K shares, a 69.91% increase from fiscal 2023.
- MaxCyte, Inc. stock issued during period, shares, employee stock purchase plans for fiscal 2023 was 82.42K shares.
| Period end | Stock Issued During Period, Shares, Employee Stock Purchase Plans 3 month | Stock Issued During Period, Shares, Employee Stock Purchase Plans 12 month |
|---|---|---|
| 2025-12-31 | 130.65K shares 10-K · filed 2026-03-25 | |
| 2024-12-31 | 70.84K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 140.05K shares 10-K · filed 2026-03-25 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | |
| 2023-12-31 | 82.42K shares 10-K · filed 2025-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |